Nebivolol

Generic name: Pronounced as (ne biv' oh lol)
Brand names
  • Bystolic®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 09/15/2016

Nebivolol is used alone or in combination with other medications to treat high blood pressure. Nebivolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure.

High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Nebivolol comes as a tablet to take by mouth. It is usually taken with or without food once a day. To help you remember to take nebivolol, take it around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take nebivolol exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor may start you on a low dose of nebivolol and gradually increase your dose not more than once every 2 weeks.

Nebivolol controls high blood pressure but does not cure it. It may take 2 weeks before the full benefit of nebivolol is seen in blood pressure readings. Continue to take nebivolol even if you feel well. Do not stop taking nebivolol without talking to your doctor. If you suddenly stop taking nebivolol it may cause angina (chest pain), heart attack, or irregular heartbeat. Your doctor will probably decrease your dose gradually over 1 to 2 weeks.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking nebivolol,

  • tell your doctor and pharmacist if you are allergic to nebivolol, any other medications, or any of the ingredients in nebivolol tablets. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: amiodarone (Cordarone, Pacerone); beta blockers such as acebutolol (Sectral), atenolol (Tenormin, in Tenoretic), betaxolol, bisoprolol (Zebeta, in Ziac), carvedilol (Coreg), labetalol, metoprolol (Lopressor, Toprol XL), nadolol (Corgard, in Corzide), pindolol, propranolol (Inderal, InnoPran XL, in Inderide), sotalol (Betapace, Betapace AF, Sorine), timolol; bupropion (Aplenzin, Forfivo XL, Wellbutrin, Zyban); calcium channel blockers such as diltiazem (Cardizem, Dilacor, others) and verapamil (Calan, Covera, Isoptin, Verelan, in Tarka); chlorpheniramine (antihistamine in allergy and cold medications); cimetidine; clomipramine (Anafranil); clonidine (Catapres, Kapvay, in Clorpres); digoxin (Lanoxin); disopyramide (Norpace); duloxetine (Cymbalta); fluoxetine (Prozac, Sarafem, Selfemra, in Symbyax); haloperidol (Haldol); insulin; oral medications for diabetes; methadone (Dolophine, Methadose); paroxetine (Paxil); propafenone (Rythmol); quinidine; reserpine; ritonavir (Norvir, in Kaletra); and sildenafil (Revatio, Viagra). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have a slow heart rate, heart or liver disease, or heart failure. Your doctor may tell you not to take nebivolol.

  • tell your doctor if you have or have ever had asthma or other lung diseases, diabetes, hyperthyroidism (an overactive thyroid gland), problems with blood circulation, kidney disease, severe allergies, or pheochromocytoma (a tumor that develops on a gland near the kidneys and may cause high blood pressure and fast heart rate).

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking nebivolol, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking nebivolol.

  • you should know that nebivolol may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.

  • you should know that if you have allergic reactions to different substances, your reactions may be worse while you are using nebivolol, and your allergic reactions may not respond to the usual doses of injectable epinephrine.

If your doctor prescribes a low-salt or low-sodium diet, follow those directions carefully.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Nebivolol may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • headache

    • tiredness

    • weakness

    • dizziness

    • diarrhea

    • nausea

    • stomach pain

    • difficulty falling asleep or staying asleep

    • numbness, burning, or tingling in the hands, arms, feet, or legs

  • Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:

    • chest pain

    • slow heart rate

    • difficulty breathing

    • unusual weight gain

    • rash

    • swelling of the hands, feet, ankles, or lower legs

  • Nebivolol may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • slow heart rate

  • dizziness or fainting

  • shakiness

  • sweating

  • confusion

  • nervousness, irritability, or sudden changes in behavior or mood

  • headache

  • numbness or tingling around the mouth

  • weakness

  • pale skin

  • sudden hunger

  • clumsy or jerky movements

  • difficulty breathing

  • seizures

  • tiredness

  • vomiting

Keep all appointments with your doctor. Your blood pressure should be checked regularly to determine your response to nebivolol. Your doctor may ask you to check your pulse (heart rate). Ask your pharmacist or doctor to teach you how to take your pulse. If your pulse is faster or slower than it should be, call your doctor.

Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking nebivolol.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Repaglinide Repaglinide The therapeutic efficacy of Nebivolol can be increased when used in combination with Repaglinide.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nebivolol.
Delavirdine Delavirdine The metabolism of Nebivolol can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Nebivolol can be decreased when combined with Nevirapine.
Dolasetron Dolasetron The metabolism of Nebivolol can be decreased when combined with Dolasetron.
Aminophylline Aminophylline The risk or severity of adverse effects can be increased when Nebivolol is combined with Aminophylline.
Calcium Carbonate Calcium Carbonate The therapeutic efficacy of Nebivolol can be decreased when used in combination with Calcium carbonate.
Candesartan Candesartan The risk or severity of hyperkalemia can be increased when Nebivolol is combined with Candesartan.
Cilostazol Cilostazol The metabolism of Nebivolol can be decreased when combined with Cilostazol.
Clopidogrel Clopidogrel The metabolism of Nebivolol can be decreased when combined with Clopidogrel.
Fenofibrate Fenofibrate The metabolism of Nebivolol can be decreased when combined with Fenofibrate.
Guanfacine Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Nebivolol.
Methylergonovine Methylergonovine Methylergometrine may increase the hypertensive and vasoconstricting activities of Nebivolol.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Nebivolol.
Naratriptan Naratriptan Naratriptan may decrease the antihypertensive activities of Nebivolol.
Olsalazine Olsalazine Olsalazine may decrease the antihypertensive activities of Nebivolol.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Nebivolol.
Penbutolol Penbutolol Acebutolol may increase the arrhythmogenic activities of Nebivolol.
Potassium Potassium Potassium cation may increase the hyperkalemic activities of Nebivolol.
Ranitidine Ranitidine The metabolism of Nebivolol can be decreased when combined with Ranitidine.
Reserpine Reserpine Reserpine may increase the hypotensive activities of Nebivolol.
Rizatriptan Rizatriptan Rizatriptan may decrease the antihypertensive activities of Nebivolol.
Sumatriptan Sumatriptan Sumatriptan may decrease the antihypertensive activities of Nebivolol.
Tacrolimus Tacrolimus The risk or severity of hyperkalemia can be increased when Tacrolimus is combined with Nebivolol.
Tizanidine Tizanidine The therapeutic efficacy of Tizanidine can be decreased when used in combination with Nebivolol.
Zolmitriptan Zolmitriptan Zolmitriptan may decrease the antihypertensive activities of Nebivolol.
Fluconazole Injection Fluconazole Injection The metabolism of Nebivolol can be decreased when combined with Fluconazole.
Meperidine Injection Meperidine Injection The metabolism of Nebivolol can be decreased when combined with Meperidine.
Metoclopramide Injection Metoclopramide Injection The metabolism of Nebivolol can be decreased when combined with Metoclopramide.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Nebivolol.
Altretamine Altretamine The therapeutic efficacy of Nebivolol can be decreased when used in combination with Amphetamine.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Nebivolol.
Ondansetron Ondansetron The metabolism of Nebivolol can be decreased when combined with Ondansetron.
Enoxaparin Injection Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Enoxaparin is combined with Nebivolol.
Torsemide Torsemide Torasemide may increase the hypotensive activities of Nebivolol.
Olanzapine Olanzapine Nebivolol may increase the orthostatic hypotensive activities of Olanzapine.
Dofetilide Dofetilide Dofetilide may increase the arrhythmogenic activities of Nebivolol.
Entacapone Entacapone The metabolism of Nebivolol can be decreased when combined with Entacapone.
Eprosartan Eprosartan The risk or severity of hyperkalemia can be increased when Nebivolol is combined with Eprosartan.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Nebivolol.
Meloxicam Meloxicam Meloxicam may decrease the antihypertensive activities of Nebivolol.
Oxcarbazepine Oxcarbazepine The metabolism of Nebivolol can be decreased when combined with Oxcarbazepine.
Pantoprazole Pantoprazole The metabolism of Nebivolol can be decreased when combined with Pantoprazole.
Telmisartan Telmisartan The metabolism of Telmisartan can be decreased when combined with Nebivolol.
Anakinra Anakinra The metabolism of Nebivolol can be increased when combined with Anakinra.
Linezolid Linezolid Linezolid may increase the hypotensive activities of Nebivolol.
Rivastigmine Rivastigmine Nebivolol may increase the bradycardic activities of Rivastigmine.
Trimipramine Trimipramine The metabolism of Nebivolol can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Nebivolol can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Nebivolol can be decreased when combined with Modafinil.
Perindopril Perindopril Perindopril may increase the hypotensive activities of Nebivolol.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the antihypertensive activities of Nebivolol.
Dutasteride Dutasteride Dutasteride may decrease the antihypertensive activities of Nebivolol.
Epinephrine Injection Epinephrine Injection The therapeutic efficacy of Epinephrine can be decreased when used in combination with Nebivolol.
Eplerenone Eplerenone The risk or severity of hyperkalemia can be increased when Eplerenone is combined with Nebivolol.
Escitalopram Escitalopram The serum concentration of Nebivolol can be increased when it is combined with Escitalopram.
Olmesartan Olmesartan The risk or severity of hyperkalemia can be increased when Nebivolol is combined with Olmesartan.
Zonisamide Zonisamide The risk or severity of bradycardia can be increased when Zonisamide is combined with Nebivolol.
Adalimumab Injection Adalimumab Injection The metabolism of Nebivolol can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of hypotension can be increased when Aripiprazole is combined with Nebivolol.
Atomoxetine Atomoxetine The metabolism of Nebivolol can be decreased when combined with Atomoxetine.
Dexmethylphenidate Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Nebivolol.
Almotriptan Almotriptan Almotriptan may decrease the antihypertensive activities of Nebivolol.
Eletriptan Eletriptan Eletriptan may decrease the antihypertensive activities of Nebivolol.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be decreased when Mefloquine is combined with Nebivolol.
Vardenafil Vardenafil Vardenafil may increase the antihypertensive activities of Nebivolol.
Alfuzosin Alfuzosin Alfuzosin may increase the hypotensive activities of Nebivolol.
Aprepitant Aprepitant The metabolism of Nebivolol can be decreased when combined with Aprepitant.
Memantine Memantine Memantine may increase the bradycardic activities of Nebivolol.
Tegaserod Tegaserod The metabolism of Nebivolol can be decreased when combined with Tegaserod.
Tadalafil Tadalafil Tadalafil may increase the antihypertensive activities of Nebivolol.
Frovatriptan Frovatriptan Frovatriptan may decrease the antihypertensive activities of Nebivolol.
Progesterone Progesterone The metabolism of Nebivolol can be decreased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Nebivolol.
Infliximab Injection Infliximab Injection The metabolism of Nebivolol can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of hypertension can be increased when Protriptyline is combined with Nebivolol.
Rifaximin Rifaximin The metabolism of Nebivolol can be increased when combined with Rifaximin.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Nebivolol is combined with Duloxetine.
Trospium Trospium The metabolism of Nebivolol can be decreased when combined with Trospium.
Bosentan Bosentan Bosentan may increase the hypotensive activities of Nebivolol.
Cinacalcet Cinacalcet The metabolism of Nebivolol can be decreased when combined with Cinacalcet.
Erlotinib Erlotinib The metabolism of Nebivolol can be decreased when combined with Erlotinib.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be increased when used in combination with Nebivolol.
Solifenacin Solifenacin Solifenacin may decrease the antihypertensive activities of Nebivolol.
Voriconazole Voriconazole The metabolism of Nebivolol can be decreased when combined with Voriconazole.
Dextroamphetamine Dextroamphetamine The therapeutic efficacy of Nebivolol can be decreased when used in combination with Amphetamine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Nebivolol can be decreased when combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be increased when used in combination with Nebivolol.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be increased when used in combination with Nebivolol.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the hypotensive activities of Nebivolol.
Ramelteon Ramelteon The metabolism of Nebivolol can be decreased when combined with Ramelteon.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Nebivolol.
Fentanyl Fentanyl Fentanyl may decrease the antihypertensive activities of Nebivolol.
Pregabalin Pregabalin Pregabalin may increase the arrhythmogenic activities of Nebivolol.
Phenylephrine Phenylephrine The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Nebivolol.
Tipranavir Tipranavir The metabolism of Tipranavir can be decreased when combined with Nebivolol.
Felbamate Felbamate The metabolism of Nebivolol can be decreased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be increased when used in combination with Nebivolol.
Ranolazine Ranolazine The serum concentration of Nebivolol can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Nebivolol can be increased when combined with Abatacept.
Rasagiline Rasagiline Rasagiline may increase the hypotensive activities of Nebivolol.
Imatinib Imatinib The metabolism of Nebivolol can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The therapeutic efficacy of Nebivolol can be increased when used in combination with Sitagliptin.
Varenicline Varenicline The risk or severity of adverse effects can be increased when Nebivolol is combined with Varenicline.
Gefitinib Gefitinib The metabolism of Nebivolol can be decreased when combined with Gefitinib.
Albuterol Albuterol The therapeutic efficacy of Salbutamol can be decreased when used in combination with Nebivolol.
Paliperidone Paliperidone Nebivolol may increase the orthostatic hypotensive activities of Paliperidone.
Bortezomib Bortezomib The metabolism of Nebivolol can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Nebivolol.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Nebivolol.
Primaquine Primaquine The metabolism of Nebivolol can be decreased when combined with Primaquine.
Rituximab Injection Rituximab Injection Nebivolol may increase the hypotensive activities of Rituximab.
Aliskiren Aliskiren The risk or severity of hyperkalemia can be increased when Nebivolol is combined with Aliskiren.
Lisdexamfetamine Lisdexamfetamine The therapeutic efficacy of Nebivolol can be decreased when used in combination with Lisdexamfetamine.
Nabilone Nabilone The risk or severity of adverse effects can be increased when Nabilone is combined with Nebivolol.
Sorafenib Sorafenib The metabolism of Nebivolol can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The therapeutic efficacy of Nebivolol can be increased when used in combination with Sunitinib.
Lapatinib Lapatinib The metabolism of Nebivolol can be decreased when combined with Lapatinib.
Mexiletine Mexiletine Mexiletine may increase the arrhythmogenic activities of Nebivolol.
Armodafinil Armodafinil The metabolism of Nebivolol can be decreased when combined with Armodafinil.
Temsirolimus Temsirolimus The metabolism of Nebivolol can be decreased when combined with Temsirolimus.
Nilotinib Nilotinib The metabolism of Nebivolol can be decreased when combined with Nilotinib.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Nebivolol can be decreased when combined with Chloramphenicol.
Desmopressin Desmopressin Desmopressin may decrease the antihypertensive activities of Nebivolol.
Betaine Betaine Glycine betaine may increase the bradycardic activities of Nebivolol.
Etravirine Etravirine The metabolism of Nebivolol can be decreased when combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Nebivolol.
Desvenlafaxine Desvenlafaxine The serum concentration of Nebivolol can be increased when it is combined with Desvenlafaxine.
Cevimeline Cevimeline The risk or severity of adverse effects can be increased when Nebivolol is combined with Cevimeline.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Nebivolol.
Pilocarpine Pilocarpine The risk or severity of adverse effects can be increased when Nebivolol is combined with Pilocarpine.
Flecainide Flecainide Nebivolol may increase the arrhythmogenic activities of Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Nebivolol can be increased when combined with Certolizumab pegol.
Praziquantel Praziquantel The metabolism of Nebivolol can be decreased when combined with Praziquantel.
Silodosin Silodosin Nebivolol may increase the orthostatic hypotensive activities of Silodosin.
Milnacipran Milnacipran The serum concentration of Nebivolol can be increased when it is combined with Milnacipran.
Dexlansoprazole Dexlansoprazole The metabolism of Nebivolol can be decreased when combined with Dexlansoprazole.
Sodium Phosphate Sodium Phosphate Sodium phosphate, monobasic may increase the hyperkalemic activities of Nebivolol.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Nebivolol.
Betaxolol Betaxolol Betaxolol may increase the arrhythmogenic activities of Nebivolol.
Iloperidone Iloperidone Nebivolol may increase the orthostatic hypotensive activities of Iloperidone.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Nebivolol.
Everolimus Everolimus The metabolism of Nebivolol can be decreased when combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The risk or severity of hyperkalemia can be increased when Nebivolol is combined with Tolvaptan.
Dronedarone Dronedarone Dronedarone may increase the bradycardic activities of Nebivolol.
Palonosetron Injection Palonosetron Injection The metabolism of Nebivolol can be decreased when combined with Palonosetron.
Saxagliptin Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Nebivolol.
Tapentadol Tapentadol The metabolism of Nebivolol can be decreased when combined with Tapentadol.
Golimumab Injection Golimumab Injection The metabolism of Nebivolol can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Nebivolol can be decreased when combined with Pazopanib.
Asenapine Asenapine Nebivolol may increase the orthostatic hypotensive activities of Asenapine.
Albendazole Albendazole The metabolism of Nebivolol can be decreased when combined with Albendazole.
Oxymorphone Oxymorphone The metabolism of Nebivolol can be decreased when combined with Oxymorphone.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be increased when used in combination with Nebivolol.
Tocilizumab Injection Tocilizumab Injection The metabolism of Nebivolol can be increased when combined with Tocilizumab.
Fingolimod Fingolimod Nebivolol may increase the bradycardic activities of Fingolimod.
Lurasidone Lurasidone Lurasidone may decrease the antihypertensive activities of Nebivolol.
Acetaminophen Injection Acetaminophen Injection The metabolism of Nebivolol can be decreased when combined with Acetaminophen.
Vilazodone Vilazodone The metabolism of Nebivolol can be decreased when combined with Vilazodone.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nebivolol.
Terbutaline Injection Terbutaline Injection The therapeutic efficacy of Terbutaline can be decreased when used in combination with Nebivolol.
Azilsartan Azilsartan The risk or severity of hyperkalemia can be increased when Azilsartan medoxomil is combined with Nebivolol.
Linagliptin Linagliptin The therapeutic efficacy of Nebivolol can be increased when used in combination with Linagliptin.
Rilpivirine Rilpivirine The metabolism of Nebivolol can be decreased when combined with Rilpivirine.
Potassium Iodide Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Nebivolol.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Nebivolol can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The metabolism of Nebivolol can be decreased when combined with Abiraterone.
Ruxolitinib Ruxolitinib Ruxolitinib may increase the bradycardic activities of Nebivolol.
Clobazam Clobazam The metabolism of Nebivolol can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The metabolism of Nebivolol can be decreased when combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Nebivolol can be decreased when combined with Vismodegib.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Nebivolol.
Crizotinib Crizotinib Nebivolol may increase the bradycardic activities of Crizotinib.
Cabergoline Cabergoline Cabergoline may increase the hypertensive and vasoconstricting activities of Nebivolol.
Ambrisentan Ambrisentan Nebivolol may increase the hypotensive activities of Ambrisentan.
Iloprost Iloprost Iloprost may increase the hypotensive activities of Nebivolol.
Enzalutamide Enzalutamide The metabolism of Nebivolol can be increased when combined with Enzalutamide.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Nebivolol.
Regorafenib Regorafenib Regorafenib may increase the bradycardic activities of Nebivolol.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be increased when used in combination with Nebivolol.
Tofacitinib Tofacitinib Nebivolol may increase the bradycardic activities of Tofacitinib.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Nebivolol.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Nebivolol.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Nebivolol.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Nebivolol.
Methazolamide Methazolamide The risk or severity of adverse effects can be increased when Methazolamide is combined with Nebivolol.
Dabrafenib Dabrafenib The serum concentration of Nebivolol can be decreased when it is combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Nebivolol can be decreased when combined with Ospemifene.
Levomilnacipran Levomilnacipran The serum concentration of Nebivolol can be increased when it is combined with Levomilnacipran.
Vortioxetine Vortioxetine The metabolism of Nebivolol can be decreased when combined with Vortioxetine.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Nebivolol.
Avanafil Avanafil Avanafil may increase the antihypertensive activities of Nebivolol.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the antihypertensive activities of Nebivolol.
Obinutuzumab Injection Obinutuzumab Injection Nebivolol may increase the hypotensive activities of Obinutuzumab.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Nebivolol can be increased when used in combination with Dapagliflozin.
Apremilast Apremilast The metabolism of Nebivolol can be increased when combined with Apremilast.
Droxidopa Droxidopa The therapeutic efficacy of Droxidopa can be decreased when used in combination with Nebivolol.
Ceritinib Ceritinib Nebivolol may increase the bradycardic activities of Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Nebivolol can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be increased when used in combination with Nebivolol.
Eslicarbazepine Eslicarbazepine The metabolism of Nebivolol can be decreased when combined with Eslicarbazepine.
Testosterone Injection Testosterone Injection The metabolism of Nebivolol can be decreased when combined with Testosterone.
Oritavancin Injection Oritavancin Injection The metabolism of Nebivolol can be decreased when combined with Oritavancin.
Empagliflozin Empagliflozin The therapeutic efficacy of Nebivolol can be increased when used in combination with Empagliflozin.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be increased when used in combination with Nebivolol.
Methamphetamine Methamphetamine The therapeutic efficacy of Nebivolol can be decreased when used in combination with Metamfetamine.
Riociguat Riociguat Nebivolol may increase the hypotensive activities of Riociguat.
Lanreotide Injection Lanreotide Injection Nebivolol may increase the bradycardic activities of Lanreotide.
Secukinumab Injection Secukinumab Injection The metabolism of Nebivolol can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection Nebivolol may increase the hypotensive activities of Risperidone.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be increased when used in combination with Nebivolol.
Lenvatinib Lenvatinib The metabolism of Nebivolol can be decreased when combined with Lenvatinib.
Naloxegol Naloxegol The metabolism of Nebivolol can be decreased when combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Nebivolol can be decreased when combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Dinutuximab is combined with Nebivolol.
Haloperidol Injection Haloperidol Injection The serum concentration of Nebivolol can be increased when it is combined with Haloperidol.
Ivabradine Ivabradine Nebivolol may increase the bradycardic activities of Ivabradine.
Amiloride Amiloride The risk or severity of hyperkalemia can be increased when Amiloride is combined with Nebivolol.
Macitentan Macitentan Nebivolol may increase the hypotensive activities of Macitentan.
Flibanserin Flibanserin Flibanserin may decrease the antihypertensive activities of Nebivolol.
Rolapitant Rolapitant The metabolism of Nebivolol can be decreased when combined with Rolapitant.
Brexpiprazole Brexpiprazole Nebivolol may increase the orthostatic hypotensive activities of Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection Nebivolol may increase the antihypertensive activities of Ziprasidone.
Cariprazine Cariprazine Cariprazine may decrease the antihypertensive activities of Nebivolol.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be increased when used in combination with Nebivolol.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Nebivolol.
Rifapentine Rifapentine The metabolism of Nebivolol can be increased when combined with Rifapentine.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nebivolol.
Cobicistat Cobicistat The metabolism of Nebivolol can be decreased when combined with Cobicistat.
Midodrine Midodrine The therapeutic efficacy of Midodrine can be decreased when used in combination with Nebivolol.
Selexipag Selexipag Nebivolol may increase the hypotensive activities of Selexipag.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Nebivolol can be decreased when combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Furosemide may increase the hypotensive activities of Nebivolol.
Rucaparib Rucaparib The metabolism of Nebivolol can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be increased when used in combination with Nebivolol.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Nebivolol can be decreased when combined with Doxepin.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Nebivolol.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Nebivolol.
Safinamide Safinamide Safinamide may increase the hypotensive activities of Nebivolol.
Midostaurin Midostaurin The metabolism of Nebivolol can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Nebivolol can be decreased when combined with Enasidenib.
Letermovir Letermovir The metabolism of Nebivolol can be increased when combined with Letermovir.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be increased when used in combination with Nebivolol.
Tetrabenazine Tetrabenazine The metabolism of Nebivolol can be decreased when combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Nebivolol.
Buprenorphine Injection Buprenorphine Injection The metabolism of Nebivolol can be decreased when combined with Buprenorphine.
Apalutamide Apalutamide The serum concentration of Nebivolol can be increased when it is combined with Apalutamide.
Fostamatinib Fostamatinib Fostamatinib may increase the antihypertensive activities of Nebivolol.
Lofexidine Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Nebivolol.
Eliglustat Eliglustat The metabolism of Nebivolol can be decreased when combined with Eliglustat.
Encorafenib Encorafenib The metabolism of Encorafenib can be decreased when combined with Nebivolol.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Nebivolol.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Nebivolol.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Nebivolol.
Dacomitinib Dacomitinib The metabolism of Nebivolol can be decreased when combined with Dacomitinib.
Stiripentol Stiripentol The metabolism of Nebivolol can be decreased when combined with Stiripentol.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Nebivolol.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Paclitaxel is combined with Nebivolol.
Rifamycin Rifamycin The metabolism of Nebivolol can be increased when combined with Rifamycin.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Nebivolol can be increased when combined with Emapalumab.
Siponimod Siponimod Siponimod may decrease the antihypertensive activities of Nebivolol.
Esomeprazole Injection Esomeprazole Injection The metabolism of Nebivolol can be decreased when combined with Esomeprazole.
Alpelisib Alpelisib The metabolism of Nebivolol can be decreased when combined with Alpelisib.
Solriamfetol Solriamfetol Solriamfetol may decrease the antihypertensive activities of Nebivolol.
Triclabendazole Triclabendazole The metabolism of Nebivolol can be decreased when combined with Triclabendazole.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Nebivolol.
Pitolisant Pitolisant The serum concentration of Nebivolol can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib The metabolism of Fedratinib can be decreased when combined with Nebivolol.
Phenytoin Injection Phenytoin Injection The metabolism of Nebivolol can be decreased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Nebivolol can be decreased when combined with Fosphenytoin.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Nebivolol.
Lasmiditan Lasmiditan Lasmiditan may increase the bradycardic activities of Nebivolol.
Calcium Acetate Calcium Acetate The therapeutic efficacy of Nebivolol can be decreased when used in combination with Calcium acetate.
Cenobamate Cenobamate The serum concentration of Nebivolol can be decreased when it is combined with Cenobamate.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Nebivolol.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Nebivolol.
Selpercatinib Selpercatinib Selpercatinib may decrease the antihypertensive activities of Nebivolol.
Fenfluramine Fenfluramine The metabolism of Nebivolol can be decreased when combined with Fenfluramine.
Octreotide Octreotide The serum concentration of the active metabolites of Nebivolol can be increased when Nebivolol is used in combination with Octreotide.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Nebivolol can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection Naxitamab may decrease the antihypertensive activities of Nebivolol.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The risk or severity of hyperkalemia can be increased when Drospirenone is combined with Nebivolol.
Theophylline Theophylline The metabolism of Nebivolol can be decreased when combined with Theophylline.
Fenoprofen Fenoprofen Fenoprofen may decrease the antihypertensive activities of Nebivolol.
Indomethacin Indomethacin Indomethacin may decrease the antihypertensive activities of Nebivolol.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the antihypertensive activities of Nebivolol.
Naproxen Naproxen Naproxen may decrease the antihypertensive activities of Nebivolol.
Tolmetin Tolmetin Tolmetin may decrease the antihypertensive activities of Nebivolol.
Sulindac Sulindac Sulindac may decrease the antihypertensive activities of Nebivolol.
Trazodone Trazodone The serum concentration of Nebivolol can be increased when it is combined with Trazodone.
Hydroxyurea Hydroxyurea The metabolism of Nebivolol can be decreased when combined with Hydroxyurea.
Phenobarbital Phenobarbital The metabolism of Nebivolol can be decreased when combined with Phenobarbital.
Primidone Primidone The metabolism of Nebivolol can be decreased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of bradycardia can be increased when Methsuximide is combined with Nebivolol.
Diethylpropion Diethylpropion The therapeutic efficacy of Nebivolol can be decreased when used in combination with Diethylpropion.
Chlorpromazine Chlorpromazine The metabolism of Nebivolol can be decreased when combined with Chlorpromazine.
Diazepam Diazepam The metabolism of Nebivolol can be decreased when combined with Diazepam.
Phenoxybenzamine Phenoxybenzamine Nebivolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.
Codeine Codeine The metabolism of Nebivolol can be decreased when combined with Codeine.
Bromocriptine Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Nebivolol.
Metaproterenol Metaproterenol The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Nebivolol.
Tranylcypromine Tranylcypromine The metabolism of Nebivolol can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine Phenelzine may increase the hypotensive activities of Nebivolol.
Procarbazine Procarbazine Procarbazine may increase the hypotensive activities of Nebivolol.
Ergoloid Mesylates Ergoloid Mesylates Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Nebivolol.
Prochlorperazine Prochlorperazine The serum concentration of Nebivolol can be increased when it is combined with Prochlorperazine.
Thioridazine Thioridazine The metabolism of Nebivolol can be decreased when combined with Thioridazine.
Trifluoperazine Trifluoperazine The serum concentration of Nebivolol can be increased when it is combined with Trifluoperazine.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Nebivolol can be increased when used in combination with Sulfadiazine.
Oxycodone Oxycodone The metabolism of Nebivolol can be decreased when combined with Oxycodone.
Methadone Methadone The metabolism of Nebivolol can be decreased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Nebivolol can be decreased when combined with Oxybutynin.
Benztropine Benztropine The metabolism of Nebivolol can be decreased when combined with Benzatropine.
Maprotiline Maprotiline The metabolism of Nebivolol can be decreased when combined with Maprotiline.
Ibuprofen Ibuprofen Ibuprofen may decrease the antihypertensive activities of Nebivolol.
Orphenadrine Orphenadrine The metabolism of Nebivolol can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The serum concentration of Nebivolol can be increased when it is combined with Perphenazine.
Fluphenazine Fluphenazine The serum concentration of Nebivolol can be increased when it is combined with Fluphenazine.
Phentermine Phentermine The therapeutic efficacy of Nebivolol can be decreased when used in combination with Phentermine.
Methylphenidate Methylphenidate Methylphenidate may decrease the antihypertensive activities of Nebivolol.
Amoxapine Amoxapine The metabolism of Nebivolol can be decreased when combined with Amoxapine.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the antihypertensive activities of Nebivolol.
Doxorubicin Doxorubicin The metabolism of Nebivolol can be decreased when combined with Doxorubicin.
Mechlorethamine Mechlorethamine Mechlorethamine may increase the bradycardic activities of Nebivolol.
Pyridostigmine Pyridostigmine Pyridostigmine may increase the bradycardic activities of Nebivolol.
Carbamazepine Carbamazepine The metabolism of Nebivolol can be decreased when combined with Carbamazepine.
Methyldopa Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Nebivolol.
Clonidine Clonidine The risk or severity of hypotension can be increased when Clonidine is combined with Nebivolol.
Prazosin Prazosin The risk or severity of hypotension can be increased when Prazosin is combined with Nebivolol.
Hydralazine Hydralazine Hydralazine may increase the hypotensive activities of Nebivolol.
Cimetidine Cimetidine The metabolism of Nebivolol can be decreased when combined with Cimetidine.
Warfarin Warfarin The metabolism of Nebivolol can be decreased when combined with Warfarin.
Loperamide Loperamide The risk or severity of bradycardia can be increased when Loperamide is combined with Nebivolol.
Promethazine Promethazine The serum concentration of Nebivolol can be increased when it is combined with Promethazine.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the antihypertensive activities of Nebivolol.
Nitrofurantoin Nitrofurantoin The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nebivolol.
Digoxin Digoxin Nebivolol may increase the arrhythmogenic activities of Digoxin.
Chloroquine Chloroquine The metabolism of Nebivolol can be decreased when combined with Chloroquine.
Quinine Quinine The metabolism of Nebivolol can be decreased when combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of bradycardia can be increased when Ethosuximide is combined with Nebivolol.
Triamterene Triamterene The risk or severity of hyperkalemia can be increased when Triamterene is combined with Nebivolol.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Nebivolol can be increased when used in combination with Chlorothiazide.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the hypotensive activities of Nebivolol.
Metolazone Metolazone Metolazone may increase the hypotensive activities of Nebivolol.
Secobarbital Secobarbital The serum concentration of Nebivolol can be decreased when it is combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Nebivolol.
Amitriptyline Amitriptyline The metabolism of Nebivolol can be decreased when combined with Amitriptyline.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Nebivolol.
Probenecid Probenecid The metabolism of Nebivolol can be decreased when combined with Probenecid.
Quinidine Quinidine Quinidine may increase the arrhythmogenic activities of Nebivolol.
Procainamide Procainamide Nebivolol may increase the arrhythmogenic activities of Procainamide.
Isoniazid Isoniazid The metabolism of Nebivolol can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Nebivolol can be increased when combined with Rifampicin.
Disopyramide Disopyramide Disopyramide may increase the bradycardic activities of Nebivolol.
Valproic Acid Valproic Acid The metabolism of Nebivolol can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Nebivolol can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital Butabarbital may increase the hypotensive activities of Nebivolol.
Levothyroxine Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Nebivolol.
Liothyronine Liothyronine The therapeutic efficacy of Liothyronine can be decreased when used in combination with Nebivolol.
Methimazole Methimazole The excretion of Nebivolol can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Nebivolol.
Glucagon Injection Glucagon Injection The therapeutic efficacy of Nebivolol can be decreased when used in combination with Glucagon.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Nebivolol.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Nebivolol.
Dextromethorphan Dextromethorphan The metabolism of Nebivolol can be decreased when combined with Dextromethorphan.
Niacin Niacin The metabolism of Nebivolol can be decreased when combined with Niacin.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Nebivolol.
Clemastine Clemastine The metabolism of Nebivolol can be decreased when combined with Clemastine.
Chlorpheniramine Chlorpheniramine The metabolism of Nebivolol can be decreased when combined with Chlorpheniramine.
Meclizine Meclizine The metabolism of Nebivolol can be decreased when combined with Meclizine.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Nebivolol can be increased when used in combination with Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide The therapeutic efficacy of Nebivolol can be increased when used in combination with Hydrochlorothiazide.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Nebivolol.
Chlorzoxazone Chlorzoxazone The metabolism of Nebivolol can be decreased when combined with Chlorzoxazone.
Carisoprodol Carisoprodol The metabolism of Nebivolol can be decreased when combined with Carisoprodol.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Propranolol may increase the arrhythmogenic activities of Nebivolol.
Minoxidil Minoxidil Minoxidil may increase the hypotensive activities of Nebivolol.
Pseudoephedrine Pseudoephedrine The therapeutic efficacy of Nebivolol can be decreased when used in combination with Pseudoephedrine.
Nortriptyline Nortriptyline The metabolism of Nebivolol can be decreased when combined with Nortriptyline.
Spironolactone Spironolactone The therapeutic efficacy of Nebivolol can be decreased when used in combination with Spironolactone.
Amphotericin B Injection Amphotericin B Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nebivolol.
Mercaptopurine Mercaptopurine The therapeutic efficacy of Mercaptopurine can be decreased when used in combination with Nebivolol.
Nadolol Nadolol Nadolol may increase the arrhythmogenic activities of Nebivolol.
Papaverine Papaverine The risk or severity of adverse effects can be increased when Papaverine is combined with Nebivolol.
Ketoconazole Ketoconazole The metabolism of Nebivolol can be decreased when combined with Ketoconazole.
Thiotepa Injection Thiotepa Injection Thiotepa may increase the bradycardic activities of Nebivolol.
Captopril Captopril The risk or severity of hyperkalemia can be increased when Captopril is combined with Nebivolol.
Dipyridamole Dipyridamole Dipyridamole may increase the bradycardic activities of Nebivolol.
Isoxsuprine Isoxsuprine The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Nebivolol.
Vinblastine Vinblastine The metabolism of Nebivolol can be decreased when combined with Vinblastine.
Bethanechol Bethanechol The risk or severity of adverse effects can be increased when Nebivolol is combined with Bethanechol.
Ethacrynic Acid Ethacrynic Acid The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Nebivolol.
Metoprolol Metoprolol The metabolism of Nebivolol can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The metabolism of Nebivolol can be decreased when combined with Hydroxyzine.
Aspirin Aspirin Acetylsalicylic acid may decrease the antihypertensive activities of Nebivolol.
Salsalate Salsalate Salsalate may decrease the antihypertensive activities of Nebivolol.
Hyoscyamine Hyoscyamine Hyoscyamine may increase the arrhythmogenic activities of Nebivolol.
Trimethoprim Trimethoprim The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Nebivolol.
Diltiazem Diltiazem The risk or severity of bradycardia can be increased when Diltiazem is combined with Nebivolol.
Nifedipine Nifedipine The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Nebivolol.
Timolol Timolol The risk or severity of adverse effects can be increased when Timolol is combined with Nebivolol.
Verapamil Verapamil The risk or severity of adverse effects can be increased when Verapamil is combined with Nebivolol.
Atenolol Atenolol Atenolol may increase the arrhythmogenic activities of Nebivolol.
Pindolol Pindolol The therapeutic efficacy of Nebivolol can be decreased when used in combination with Pindolol.
Cisplatin Injection Cisplatin Injection Cisplatin may increase the bradycardic activities of Nebivolol.
Diflunisal Diflunisal Diflunisal may decrease the antihypertensive activities of Nebivolol.
Piroxicam Piroxicam Piroxicam may decrease the antihypertensive activities of Nebivolol.
Bumetanide Bumetanide The risk or severity of adverse effects can be increased when Bumetanide is combined with Nebivolol.
Glyburide Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Nebivolol.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Nebivolol.
Indapamide Indapamide The therapeutic efficacy of Nebivolol can be increased when used in combination with Indapamide.
Pentoxifylline Pentoxifylline Pentoxifylline may increase the hypotensive activities of Nebivolol.
Pentamidine Injection Pentamidine Injection The therapeutic efficacy of Nebivolol can be increased when used in combination with Pentamidine.
Labetalol Labetalol The therapeutic efficacy of Nebivolol can be decreased when used in combination with Labetalol.
Gemfibrozil Gemfibrozil The metabolism of Nebivolol can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Nebivolol.
Ketoprofen Ketoprofen Ketoprofen may decrease the antihypertensive activities of Nebivolol.
Pimozide Pimozide The metabolism of Nebivolol can be decreased when combined with Pimozide.
Enalapril Enalapril The risk or severity of hyperkalemia can be increased when Enalapril is combined with Nebivolol.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the antihypertensive activities of Nebivolol.
Amiodarone Amiodarone The therapeutic efficacy of Nebivolol can be increased when used in combination with Amiodarone.
Buspirone Buspirone Buspirone may decrease the antihypertensive activities of Nebivolol.
Lovastatin Lovastatin The metabolism of Nebivolol can be decreased when combined with Lovastatin.
Mesalamine Mesalamine Mesalazine may decrease the antihypertensive activities of Nebivolol.
Diclofenac Diclofenac Diclofenac may decrease the antihypertensive activities of Nebivolol.
Fluoxetine Fluoxetine The serum concentration of Nebivolol can be increased when it is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of bradycardia can be increased when Nimodipine is combined with Nebivolol.
Clozapine Clozapine The metabolism of Clozapine can be decreased when combined with Nebivolol.
Idarubicin Idarubicin The metabolism of Nebivolol can be decreased when combined with Idarubicin.
Benazepril Benazepril The risk or severity of hyperkalemia can be increased when Benazepril is combined with Nebivolol.
Etodolac Etodolac Etodolac may decrease the antihypertensive activities of Nebivolol.
Felodipine Felodipine The risk or severity of bradycardia can be increased when Felodipine is combined with Nebivolol.
Fosinopril Fosinopril The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Nebivolol.
Nabumetone Nabumetone Nabumetone may decrease the antihypertensive activities of Nebivolol.
Quinapril Quinapril The risk or severity of hyperkalemia can be increased when Quinapril is combined with Nebivolol.
Ramipril Ramipril Ramipril may increase the hypotensive activities of Nebivolol.
Simvastatin Simvastatin The metabolism of Nebivolol can be decreased when combined with Simvastatin.
Amlodipine Amlodipine The risk or severity of bradycardia can be increased when Amlodipine is combined with Nebivolol.
Itraconazole Itraconazole The risk or severity of hyperkalemia can be increased when Itraconazole is combined with Nebivolol.
Lisinopril Lisinopril The risk or severity of hyperkalemia can be increased when Lisinopril is combined with Nebivolol.
Oxaprozin Oxaprozin Oxaprozin may decrease the antihypertensive activities of Nebivolol.
Rifabutin Rifabutin The metabolism of Nebivolol can be increased when combined with Rifabutin.
Sotalol Sotalol Nebivolol may increase the arrhythmogenic activities of Sotalol.
Bisoprolol Bisoprolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nebivolol.
Zolpidem Zolpidem The metabolism of Nebivolol can be decreased when combined with Zolpidem.
Doxazosin Doxazosin The therapeutic efficacy of Nebivolol can be decreased when used in combination with Doxazosin.
Terazosin Terazosin Nebivolol may increase the orthostatic hypotensive activities of Terazosin.
Isradipine Isradipine The risk or severity of bradycardia can be increased when Isradipine is combined with Nebivolol.
Omeprazole Omeprazole The metabolism of Nebivolol can be decreased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Nebivolol can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Nebivolol can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine The metabolism of Nebivolol can be decreased when combined with Venlafaxine.
Nizatidine Nizatidine Nizatidine may increase the bradycardic activities of Nebivolol.
Fluvoxamine Fluvoxamine The metabolism of Nebivolol can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The serum concentration of Nebivolol can be increased when it is combined with Nefazodone.
Lamotrigine Lamotrigine The risk or severity of bradycardia can be increased when Lamotrigine is combined with Nebivolol.
Losartan Losartan Losartan may increase the arrhythmogenic activities of Nebivolol.
Tramadol Tramadol The metabolism of Nebivolol can be decreased when combined with Tramadol.
Vinorelbine Injection Vinorelbine Injection The metabolism of Nebivolol can be decreased when combined with Vinorelbine.
Moexipril Moexipril The risk or severity of hyperkalemia can be increased when Moexipril is combined with Nebivolol.
Lansoprazole Lansoprazole The metabolism of Nebivolol can be decreased when combined with Lansoprazole.
Nicardipine Nicardipine The metabolism of Nebivolol can be decreased when combined with Nicardipine.
Bupropion Bupropion The metabolism of Nebivolol can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Nebivolol can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Nebivolol can be decreased when combined with Saquinavir.
Metformin Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Nebivolol.
Dalteparin Injection Dalteparin Injection The risk or severity of hyperkalemia can be increased when Nebivolol is combined with Dalteparin.
Nisoldipine Nisoldipine The risk or severity of bradycardia can be increased when Nisoldipine is combined with Nebivolol.
Amifostine Injection Amifostine Injection Nebivolol may increase the hypotensive activities of Amifostine.
Acarbose Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Nebivolol.
Glimepiride Glimepiride Nebivolol may increase the arrhythmogenic activities of Glimepiride.
Ritonavir Ritonavir The serum concentration of Nebivolol can be increased when it is combined with Ritonavir.
Clomipramine Clomipramine The metabolism of Nebivolol can be decreased when combined with Clomipramine.
Zafirlukast Zafirlukast The metabolism of Nebivolol can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine Mirtazapine may decrease the antihypertensive activities of Nebivolol.
Trandolapril Trandolapril The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Nebivolol.
Topiramate Topiramate The metabolism of Nebivolol can be decreased when combined with Topiramate.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nebivolol.
Pramipexole Pramipexole The risk or severity of adverse effects can be increased when Pramipexole is combined with Nebivolol.
Donepezil Donepezil Donepezil may increase the bradycardic activities of Nebivolol.
Nelfinavir Nelfinavir The metabolism of Nebivolol can be decreased when combined with Nelfinavir.
Carvedilol Carvedilol The risk or severity of bradycardia can be increased when Carvedilol is combined with Nebivolol.
Nilutamide Nilutamide The metabolism of Nebivolol can be decreased when combined with Nilutamide.
Selegiline Selegiline Selegiline may increase the hypotensive activities of Nebivolol.
Bicalutamide Bicalutamide The metabolism of Nebivolol can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Nebivolol can be decreased when combined with Sertraline.
Propafenone Propafenone The risk or severity of adverse effects can be increased when Propafenone is combined with Nebivolol.
Letrozole Letrozole The metabolism of Nebivolol can be decreased when combined with Letrozole.
Irbesartan Irbesartan The risk or severity of hyperkalemia can be increased when Irbesartan is combined with Nebivolol.
Tamsulosin Tamsulosin Nebivolol may increase the orthostatic hypotensive activities of Tamsulosin.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Nebivolol.
Finasteride Finasteride Finasteride may decrease the antihypertensive activities of Nebivolol.
Quetiapine Quetiapine Quetiapine may increase the hypotensive activities of Nebivolol.
Paroxetine Paroxetine The metabolism of Nebivolol can be decreased when combined with Paroxetine.
Tolcapone Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Nebivolol.
Citalopram Citalopram The metabolism of Nebivolol can be decreased when combined with Citalopram.
Efavirenz Efavirenz The metabolism of Nebivolol can be decreased when combined with Efavirenz.
Sildenafil Sildenafil The metabolism of Nebivolol can be decreased when combined with Sildenafil.
Pioglitazone Pioglitazone The therapeutic efficacy of Nebivolol can be increased when used in combination with Pioglitazone.
Celecoxib Celecoxib Celecoxib may decrease the antihypertensive activities of Nebivolol.
Rosiglitazone Rosiglitazone The therapeutic efficacy of Nebivolol can be increased when used in combination with Rosiglitazone.
Tolterodine Tolterodine The metabolism of Nebivolol can be decreased when combined with Tolterodine.
Thalidomide Thalidomide The metabolism of Nebivolol can be decreased when combined with Thalidomide.
Balsalazide Balsalazide Balsalazide may decrease the antihypertensive activities of Nebivolol.
Nateglinide Nateglinide The therapeutic efficacy of Nebivolol can be increased when used in combination with Nateglinide.
Galantamine Galantamine Galantamine may increase the bradycardic activities of Nebivolol.
Rabeprazole Rabeprazole The metabolism of Nebivolol can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Nebivolol can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists